Le Lézard
Classified in: Health
Subjects: AWD, DIS, DEI

Prime Therapeutics recognized as a Disability Equality Index® Best Place to Work for Disability Inclusion


Prime a top scorer in its first year taking the DEI

EAGAN, Minn., July 21, 2022 /PRNewswire/ -- Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) is proud to announce its score of 90 on the Disability Equality Index® (DEI), the world's most comprehensive benchmarking tool measuring workplace inclusion against competitors. By earning a top score on the DEI, Prime demonstrates its commitment to disability inclusion and equality.

"Leveraging the Disability Equality Index benchmarking tool allows us to build a roadmap of measurable and tangible actions that we can take to achieve disability inclusion and equity," said Zabrina Watkins, diversity, equity and inclusion director for Prime. "We recognize that we have a long way to go, however receiving a score of 90 out of 100 lets us know that we are making intentional and mindful progress."

Prime's commitment to disability inclusion is rooted in its collective values as a company and is inseparable from its purpose and dedication to serving others.

As detailed in its first Diversity, Equity and Inclusion Annual Transparency Report, Prime demonstrates its progress toward workplace and community equity, acknowledging the meaningful steps taken ? and required in future ? to attain a more diverse, inclusive way of doing business within its walls and in its interactions with clients and partners. The report includes disability data based on self-identification.

Additionally, Prime CEO Ken Paulus signed the Disability:IN's CEO Letter on Disability Inclusion which commits Prime to benchmarking its disability inclusion journey with the DEI. To that end, Prime continues to identify and implement accommodations for employees and on its public channels. On the mental health front, Prime will continue to provide employee and dependent resources enabling confidential support and tools for Prime leaders to guide conversations and aid in crisis situations.

Globally, people with disabilities represent over one billion people. Disability is a natural part of the human experience, and it crosses lines of age, ethnicity, gender, gender identity, race, sexual orientation, socioeconomic status and religion.

"Disability inclusion is a rapidly expanding aspect of corporate culture, and it's gratifying to partner with 415 companies on the 2022 Disability Equality Index," said Jill Houghton, President and CEO of Disability:IN. "These top-scoring companies not only excel in disability inclusion, many are also adopting emerging trends and pioneering measures that can move the disability agenda from accommodation to inclusion and ultimately, genuine belonging."

The DEI was launched in 2015 by Disability:IN and The American Association of People with Disabilities (AAPD) and is acknowledged today as the most robust disability inclusion assessment tool in business. It is modeled off the Corporate Equality Index that highlights LGBTQ+ inclusive workplace policies, for which Prime earned a score of 100% earlier this year. Now in its eighth year, the DEI exists to help businesses make a positive impact on the unemployment/underemployment of people with disabilities.

About Prime Therapeutics

Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime provides total drug management solutions for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and offers clinical services for people with complex medical conditions. Prime serves more than 33 million people. It is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. For more information visit www.primetherapeutics.com or follow @Prime_PBM on Twitter.

About the Disability Equality Index®

The Disability Equality Index (DEI) is a comprehensive benchmarking tool that helps companies build a roadmap of measurable, tangible actions that they can take to achieve disability inclusion and equality. Each company receives a score, on a scale of zero (0) to 100, with those earning 80 and above recognized as a "Best Place to Work for Disability Inclusion."

The DEI is a joint initiative of the American Association of People with Disabilities (AAPD), the nation's largest disability rights organization, and Disability:IN, the global business disability inclusion network, to collectively advance the inclusion of people with disabilities. The organizations are complementary and bring unique strengths that make the project relevant and credible to corporations and the disability community. The tool was developed by the DEI Advisory Committee, a diverse group of business leaders, policy experts, and disability advocates. Learn more at: www.DisabilityEqualityIndex.org.

About the American Association of People with Disabilities (AAPD)

AAPD is a convener, connector, and catalyst for change, increasing the political and economic power for people with disabilities. As a national cross-disability rights organization AAPD advocates for full civil rights for the 60+ million Americans with disabilities. Learn more at: www.aapd.com.

About Disability:IN®

Disability:IN is a global organization driving disability inclusion and equality in business. More than 400 corporations partner with Disability:IN to create long-term business and social impact through the world's most comprehensive disability inclusion benchmarking and reporting tool, the Disability Equality Index (DEI); best-in-class conferences and programs; expert counsel and engagement; and public policy leadership. Join us at disabilityin.org/AreYouIN #AreYouIN.

Jenine Anderson
Public Relations Manager
612.777.5629
[email protected]

SOURCE Prime Therapeutics LLC


These press releases may also interest you

at 08:10
Sangamo Therapeutics, Inc. , a genomic medicines company, today presented pre-clinical data showcasing its novel next-generation integrase technology engineered to enable large-scale genome editing. Building on Sangamo's deep expertise in protein-DNA...

at 08:09
Aquilance, a leading provider of financial administration services for high-net-worth families, individuals, and family offices, continues to gain recognition for its proprietary technology and white glove service. This year, the firm is proud to...

at 08:06
Academy Sports + Outdoors ("Academy") today announced the donation of over $530,000 to St. Jude Children's Research Hospital®. The donation is a result of a collaboration between the two organizations to create holiday-inspired t-shirts and pajamas...

at 08:05
Researchers from Mind Medicine (MindMed) Inc. (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today presented new studies highlighting the significant...

at 08:05
ECI is thrilled to unveil its strategic rebranding, which combines Enhanced Compliance, Inc. and its Costa Rica-based subsidiary CRx Life Sciences into one entity and signals a critical juncture in the company's ongoing growth and dedication to...

at 08:05
Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today reported financial results for the first quarter of 2024 and recent business highlights. "2024 is off to a great start with tremendous progress on our skeletal...



News published on and distributed by: